Heron Therapeutics Inc (HRTX) rating reiterates by Needham

Heron Therapeutics Inc’s filing revealed that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17 ’23. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.23 million. Then, Collard Craig […]

HRTX’s latest rating updates from top analysts.

In a filing, Heron Therapeutics Inc revealed its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17 ’23. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.23 million. Then, Collard […]

Heron Therapeutics Inc [HRTX] Records 50-Day SMA of $2.44

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Heron Therapeutics Inc shares valued at $27,250 were purchased by Forbes William P on Nov 17 ’23. At $1.09 per share, Forbes William P acquired 25,000 shares. The insider’s holdings grew to 79,000 shares […]

Understanding the Risks of Investing in Heron Therapeutics Inc (HRTX)

CHWY Stock

In a filing, Heron Therapeutics Inc revealed its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17 ’23. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.19 million. Then, Collard […]

HRTX’s short interest shows a sharp rise on Feb 15, 2024

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Heron Therapeutics Inc shares valued at $27,250 were purchased by Forbes William P on Nov 17 ’23. At $1.09 per share, Forbes William P acquired 25,000 shares. The insider’s holdings grew […]

Heron Therapeutics Inc [HRTX] Investment Guide: What You Need to Know

Heron Therapeutics Inc’s filing revealed that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.2 million. Then, Collard Craig A […]

Heron Therapeutics Inc [HRTX] Investment Guide: What You Need to Know

Heron Therapeutics Inc’s recent filing unveils that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0 on Nov 17. In the deal valued at $1.09 per share,25,000 shares were bought. As a result of this transaction, Forbes William P now holds 79,000 shares worth roughly $0.21 million. Then, Collard Craig […]

Heron Therapeutics Inc [HRTX] Records 50-Day SMA of $2.17

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Heron Therapeutics Inc shares valued at $27,250 were purchased by Forbes William P on Nov 17. At $1.09 per share, Forbes William P acquired 25,000 shares. The insider’s holdings grew to 79,000 shares worth approximately $0.21 million […]